Keros Therapeutics
KROS
#6172
Rank
โ‚น58.87 B
Marketcap
โ‚น1,453
Share price
-4.83%
Change (1 day)
-46.72%
Change (1 year)

Keros Therapeutics (KROS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น3.93 Billion

According to Keros Therapeutics's latest financial reports the company's total liabilities are โ‚น3.93 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Keros Therapeutics - Total liabilities on balance sheet (from 2019 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น3.14 B29.57%
2022-12-31โ‚น2.42 B170.26%
2021-12-31โ‚น0.89 B59.17%
2020-12-31โ‚น0.56 B-24.29%
2019-12-31โ‚น0.74 B-27.2%
2018-12-31โ‚น1.02 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น2.38 B-39.54%๐Ÿ‡บ๐Ÿ‡ธ USA